Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

VENTILAZIONE A PRESSIONE POSITIVA DI UN'ORA DOPO UNA PROVA DI RESPIRAZIONE SPONTANEA CON SUPPORTO PRESSORIO: UNO STUDIO CLINICO RANDOMIZZATO

18 settembre 2026 aggiornato da: Hospital do Coracao

VENTILAZIONE A PRESSIONE POSITIVA DI UN'ORA DOPO UNA PROVA DI RESPIRAZIONE SPONTANEA CON SUPPORTO PRESSORIO: STUDIO CLINICO RANDOMIZZATO

This is a randomized, open, multicenter, pragmatic, adaptive clinical trial with intention-to-treat analysis. The study will compare two weaning strategies from mechanical ventilation in critically ill patients admitted to intensive care units, with more than 72 hours of mechanical ventilation and with a successful spontaneous breathing trial on pressure support. Immediately after a successful spontaneous breathing trial, eligible patients will be randomized into 2 groups that will be treated according to one of the following interventions:1) One-hour positive pressure ventilation: as soon as the success of the spontaneous breathing trial is confirmed, the patient is submitted to mechanical ventilation for 1 hour using the previous ventilatory parameters and, afterwards, extubated.2) Immediate extubation: the patient is extubated immediately after the success of the spontaneous breathing trial.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Adaptive design for sample size. The study will include up to a maximum of 4.000 patients. First interim analysis will be performed after complete data is available for the first 500 eligible patients. The Bayesian logistic regression model will be adjusted to provide posterior probabilities that will be compared with threshold values to evaluate stopping decisions. Extensive simulations were conducted to develop and understand adaptive design performance, interim analysis timing, and decision criteria. The trial may be stopped early for efficacy or futility. Secondary outcomes will be analyzed with a gatekeeping procedure to preserve overall type I error at 0.05. Thus, the assessment of statistical significance of secondary outcomes will be performed only if the preceding outcome in the hierarchy met the threshold for statistical significance. No adjustment for multiple comparisons will be applied for analyses of tertiary outcomes and subgroups. Thus, these results should be interpreted as exploratory.Secondary outcomes tested in hierarchical order will be: (1) Mechanical ventilation free days within 28 days; (2) Hospital free days within 28 days; (3) Mortality within 28 days.

Tipo di studio

Interventistico

Iscrizione (Stimato)

4000

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Patients aged > 18 years.
  • Admitted to the intensive care unit (surgical or medical).
  • With endotracheal intubation.
  • Mechanical ventilation for more than 72 hours.
  • Who underwent successful spontaneous breathing trial (according to the study protocol) and is considered able to be extubated.

Exclusion Criteria:

  • Patients unable to obey commands.
  • With non-planned extubation.
  • Neuromuscular disease and cervical spinal cord injury.
  • Tracheostomy.
  • Contraindication for cardiopulmonary resuscitation or reintubation.
  • Terminal extubation.
  • Lack of informed consent.
  • Previously included in the trial.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Ventilazione a pressione positiva di un'ora

As soon as the success of the spontaneous breathing trial is confirmed, the patient will be submitted to one-hour positive pressure ventilation using the previous ventilatory parameters and, afterwards, extubated.

Comparatore attivo: Estubazione immediata

The patient will be extubated immediately (up to 10 minutes) after the success of the spontaneous breathing trial.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Number of Participants With Extubation Failure Within 7 Days
Lasso di tempo: 7 days (from randomization through Day 7 after randomization)

Extubation failure is defined as a composite endpoint of reintubation or death within 7 days after randomization

7 days (from randomization through Day 7 after randomization)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Ventilator-Free Days Through Day 28
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)

Ventilator-free days are defined as the number of days alive and free from invasive mechanical ventilation from randomization through Day 28 after randomization. If a patient dies before day 28, the ventilator-free days will be counted as zero. If a patient is reintubated and returns to mechanical ventilation and later is extubated again and remains in unassisted breathing until day 28, the ventilator-free days will be counted from the end of the last period of assisted breathing until day 28. An invasive mechanical ventilation period of less than 24 hours for surgical purposes will count as 1 ventilator-free day. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from mechanical ventilation for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome.

28 days (from randomization through Day 28 after randomization)
Hospital-Free Days Through Day 28
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)

Hospital-free days are defined as the number of days alive and out of the hospital from randomization through Day 28 after randomization. If a patient dies before day 28, the hospital-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from hospital for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed through day 28 to ascertain this outcome.

28 days (from randomization through Day 28 after randomization)
Number of Participants Who Died Within 28 Days
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)

All-cause mortality from randomization through day 28

28 days (from randomization through Day 28 after randomization)

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Ventilatory Support-Free Days Through Day 28
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)

Ventilatory support-free days are defined as the number of days alive and free from any ventilatory support (invasive or noninvasive) from randomization through day 28. Any use of invasive mechanical ventilation for any duration during a calendar day will count as 1 day with ventilatory support (i.e., not free). Use of noninvasive ventilatory support (noninvasive ventilation or high-flow nasal cannula) for ≥6 hours in any calendar day will count as 1 day with ventilatory support. Participants who die before day 28 will be assigned 0 ventilatory support-free days. If reintubation occurs and the participant later achieves unassisted spontaneous breathing again, ventilatory support-free days will be counted from the end of the last assisted-breathing period through day 28, provided the participant remains alive and free from ventilatory support.

28 days (from randomization through Day 28 after randomization)
Number of Participants With Extubation Failure Within 2 Days
Lasso di tempo: 2 days (from randomization through Day 2 after randomization)

Extubation failure is defined as a composite endpoint of reintubation or death within 2 days after randomization

2 days (from randomization through Day 2 after randomization)
Number of Participants With Death or Reintubation Within 28 Days
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)

Composite endpoint of reintubation or death within 28 days after randomization

28 days (from randomization through Day 28 after randomization)
Intensive Care Unit-Free Days Through Day 28
Lasso di tempo: 28 days (from randomization through Day 28 after randomization)

ICU-free days are defined as the number of days alive and out of the intensive care unit from randomization through day 28. If a patient dies before day 28, the ICU-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered as alive and free from ICU for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome.

28 days (from randomization through Day 28 after randomization)
Number of Participants Who Died in the Hospital
Lasso di tempo: From randomization to hospital discharge, up to 90 days

All-cause mortality occurring from randomization until hospital discharge (death before hospital discharge)

From randomization to hospital discharge, up to 90 days
Number of Participants Who Died in the Intensive Care Unit
Lasso di tempo: From randomization to ICU discharge, up to 90 days

All-cause mortality occurring from randomization until ICU discharge (death before ICU discharge)

From randomization to ICU discharge, up to 90 days

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 gennaio 2027

Completamento primario (Stimato)

1 dicembre 2029

Completamento dello studio (Stimato)

1 febbraio 2030

Date di iscrizione allo studio

Primo inviato

23 dicembre 2025

Primo inviato che soddisfa i criteri di controllo qualità

23 dicembre 2025

Primo Inserito (Effettivo)

7 gennaio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

22 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

18 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • GS-Wean: PSV SBT

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .